Loss of WRNIP1 or its UBZ domain results in DNA damage accumulation and enhanced chromosomal instability upon MRS
(A) Schematic representation of human WRNIP1 protein structure. Western blot analysis showing the expression of the WRNIP1 protein in wild-type cells (shWRNIP1WT), WRNIP1-deficient cells (shWRNIP1) and WRNIP1 ATPase mutant (shWRNIP1T294A) or WRNIP1 UBZ mutant (shWRNIP1D37A) cells. MRC5SV40 fibroblasts were used as a positive control. The membrane was probed with an anti-FLAG or anti-WRNIP1 antibody. GAPDH was used as a loading control.
(B) Analysis of DNA damage accumulation evaluated by alkaline Comet assay. MRC5SV, shWRNIP1, shWRNIP1D37A and shWRNIP1T294A cells were treated or not with 0.4 µM Aph for 24 h, then subjected to Comet assay. The graph shows data presented as mean tail moment ± SE from three independent experiments. Horizontal black lines represent the mean (ns, not significant; **, P < 0.01; ****, P < 0.0001; two-tailed Student’s t test). Representative images are given.
(C) Analysis of chromosomal aberrations in the indicated cell lines treated as shown in the experimental scheme. Dot plot shows the number of chromosomal aberrations per cell ± SE from three independent experiments. Horizontal black lines represent the mean (ns, not significant; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001; two-tailed Student’s t test). Representative images are given. Insets show enlarged metaphases for a better visualization of chromosomal aberrations.
(D) Evaluation of DNA damage accumulation by alkaline Comet assay. Cells were treated as shown in the experimental scheme, then subjected to Comet assay. Dot plot shows data presented as mean tail moment ± SE from three independent experiments. Horizontal black lines represent the mean (ns, not significant; ****, P < 0.0001; two-tailed Student’s t test). Representative images are given.